New study: does early use of upadacitinib prevent surgery in severe colitis?
NCT ID NCT07472309
First seen Mar 20, 2026 · Last updated May 19, 2026 · Updated 10 times
Summary
This study looked at 81 people with severe ulcerative colitis to see if starting upadacitinib early works better than using it after other treatments fail. Researchers compared how many patients avoided surgery and achieved remission. The goal is to find the best timing for this medication to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xijing Hospital,Fourth Military Medical University
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.